Dr. Chirine El Mokdad, MD

Dr. El Mokdad practices at Trinity Health Oakland Hospital in Pontiac, Michigan, part of Trinity Health.

Dr. El Mokdad's NPI, 1578054573, was assigned on May 24, 2018. Dr. El Mokdad holds Michigan license 4301505066.

Dr. El Mokdad's primary practice is Trinity Health Oakland Hospital, at 44405 Woodward Ave, Pontiac, MI 48341 in Oakland County. The practice phone is (248) 858-3000.

Dr. El Mokdad's primary practice is Trinity Health Oakland Hospital in Pontiac, Michigan, part of Trinity Health. Dr. El Mokdad is also affiliated with McLaren Oakland. The medical group on file is Mercy Hospitalists, PLLC. Dmand AI also links Dr. El Mokdad to 2 more hospitals, 4 home health agencies, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. El Mokdad practices, 10 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. El Mokdad's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. El Mokdad is licensed in Michigan.

CMS data shows 2,520 Medicare services from Dr. El Mokdad across 24 procedure codes in 2024, for 662 Medicare patients. Medicare paid $223,855 for them.

CMS counts 662 Medicare patients who saw Dr. El Mokdad in 2024. The largest group is 75 to 84, with 253 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. El Mokdad's median patient age at 72, with 60% women.

In 2024, Dr. El Mokdad wrote 14,092 Medicare Part D claims for 765 patients. 86% of them were for generic drugs. CMS names the drug for 13,258 of them, across 154 drugs with 11 or more claims each, at $1,480,733 in total drug cost. In 2023, CMS named 12,119 claims across 156 drugs.

Dr. El Mokdad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. El Mokdad as offering telehealth.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 114 general payments to Dr. El Mokdad from 21 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $556.